Replies to post #12139 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

EagleD, one major problem with your AGNPF market valuation is it literally adds zero value to long term shares prior to the reverse split:

EagleD

I am uber long with a lot of shares I would personally be shocked if I could sell my shares at $2 plus. This is a small company and it will be one of a cocktail of therapeutics. Logistics matters.

A $120 million market cap at $1 seems reasonable to me.

Current Number of Outstanding Listed Securities: 140,042,791.

FullY Diluted Shares (FDS) : Approximately 200,000,000 or less.

A USD$120M market cap per OS = .857 Cent Per Share.

A USD$200M market cap per FDS = .60 Cent Per Share.

Have a look-see @ the historical chart for AGNPF

Clearly, a $1 valuation would be nil gain for anyone holding shares anywhere near the top or the middle based on fully diluted shares.

That's a lot of people - better than most!

The CEO has consistently talked about Bellus Health as a marker for where they hope to position the company in the foreseeable future, That would include anyone or all of the pending results for 3 current Phase 2 clinical trial outcomes. The CEO has taken many opportunities to express to shareholders that during Phase 2 is where the most value (bang for the buck) is created. There's no way the CEO is thinking on such a small scale to consider $1 per share or less is real world reasonable.

A rhetorical question: Would any of ^that be considered due diligence in one’s Pennyland Playbook?

just 1 opinion,

M$
__

PostScript

I won’t deny it - some may never see eye to eye.

Rhetorically speaking, can anyone deny it's free entertainment?

all-true-istic Outro: